In cancer, IL33/ST2 signaling in Tregs seems particularly important in colon cancer, where the frequency of ST2-expressing Tregs is higher and ST2-expression is upregulated compared to normal colon tissue. Here, IL1RL1 is linked to colonic neoplasm.